Literature DB >> 6090316

Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus.

L K Riley, D C Robertson.   

Abstract

The microbicidal activities of freeze-thaw and high-salt extracts of human and bovine polymorphonuclear leukocyte (PMN) granules were tested against a smooth intermediate strain (45/0) and a rough strain (45/20) of Brucella abortus which differ in virulence and survival within PMNs. Freeze-thaw extracts of human PMN granules were more brucellacidal than high-salt extracts when supplemented with hydrogen peroxide (H2O2) and potassium iodide (KI), whereas the opposite was found with freeze-thaw and high-salt extracts of bovine PMN granules. There was no oxygen-independent killing of either the smooth or rough strain of B. abortus by amounts of granule extracts which caused 100% killing of a deep rough mutant (Re) of Salmonella typhimurium. The oxygen-dependent brucellacidal activity of granule extracts was dependent on concentrations of myeloperoxidase (MPO) units, H2O2, and KI. Maximal brucellacidal activity was observed at pH 5.5 to 6.0. The smooth strain, 45/0, was more resistant to oxygen-dependent killing by granule extracts than was the rough strain, 45/20. Granule extracts were more brucellacidal than purified MPO at equivalent levels of MPO enzyme units, suggesting that at least one other reaction enhances killing by the MPO-H2O2-I- system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090316      PMCID: PMC261460          DOI: 10.1128/iai.46.1.231-236.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A method for separation of bovine blood leukocytes for in vitro studies.

Authors:  C A Carson; D M Sells; M Ristic
Journal:  Am J Vet Res       Date:  1975-08       Impact factor: 1.156

2.  Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.

Authors:  S J Klebanoff
Journal:  Semin Hematol       Date:  1975-04       Impact factor: 3.851

3.  Mycobacterium microti may protect itself from intracellular destruction by releasing cyclic AMP into phagosomes.

Authors:  D B Lowrie; P S Jackett; N A Ratcliffe
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

4.  Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages.

Authors:  J Alexander; K Vickerman
Journal:  J Protozool       Date:  1975-11

5.  Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils.

Authors:  G L Mandell
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

6.  Character of azurophil and specific granules purified from human polymorphonuclear leukocytes.

Authors:  J K Spitznagel; F G Dalldorf; M S Leffell; J D Folds; I R Welsh; M H Cooney; L E Martin
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

7.  Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis.

Authors:  M B Goren; P D'Arcy Hart; M R Young; J A Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Role of the phagocyte in host-parasite interactions. XII. Hydrogen peroxide-myeloperoxidase bactericidal system in the phagocyte.

Authors:  R J McRipley; A J Sbarra
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

9.  Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.

Authors:  R R Friis
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

10.  The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  30 in total

1.  Regulation of Brucella abortus catalase.

Authors:  J A Kim; Z Sha; J E Mayfield
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.

Authors:  María P Jiménez de Bagüés; Antoine Gross; Annie Terraza; Jacques Dornand
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication.

Authors:  J E Ugalde; C Czibener; M F Feldman; R A Ugalde
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.

Authors:  C A Allen; L G Adams; T A Ficht
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro.

Authors:  P G Detilleux; B L Deyoe; N F Cheville
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.

Authors:  J Pizarro-Cerdá; E Moreno; V Sanguedolce; J L Mege; J P Gorvel
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes.

Authors:  P H Elzer; R W Phillips; G T Robertson; R M Roop
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

8.  Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.

Authors:  M T Labro; C Babin-Chevaye
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

9.  Brucella abortus rough mutants are cytopathic for macrophages in culture.

Authors:  Jianwu Pei; Thomas A Ficht
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.